Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Avid Bioservices, Inc. (CDMO)
Last avid bioservices, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.avidbio.com
Company Research
Source: GlobeNewswire
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 2024 -- -- Completed Convertible Debt Offering Subsequent to Quarter End, Extending Debt Maturity to 2029 -- TUSTIN, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the third quarter and nine months ended January 31, 2024. Highlights from the Quarter Ended January 31, 2024, and Other Events: "I would first like to address the reasons for our delayed 10-Q filing for the third quarter of fiscal 2024,” stated Nic
Show less
Read more
Impact Snapshot
Event Time:
CDMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDMO alerts
High impacting Avid Bioservices, Inc. news events
Weekly update
A roundup of the hottest topics
CDMO
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOGlobeNewswire
- Avid Bioservices, Inc. (NASDAQ: CDMO) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $8.00. They now have an "outperform" rating on the stock.MarketBeat
- Avid Bioservices (CDMO) Quantifies Wrongful Accounting Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities – Hagens BermanGlobeNewswire
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 [Yahoo! Finance]Yahoo! Finance
- Laughing Water Capital - Avid Bioservices: A Few Years Away From Large, Relatively Sticky FCF [Seeking Alpha]Seeking Alpha
CDMO
Earnings
- 4/24/24 - Miss
CDMO
Sec Filings
- 5/2/24 - Form 4
- 5/2/24 - Form 4
- 5/2/24 - Form 4
- CDMO's page on the SEC website